Tribe, Drugmaker Heading To Supreme Court After Bids For Rehearing, Stay Denied

Mealey's (November 16, 2018, 9:09 AM EST) -- WASHINGTON, D.C. — A Native American tribe and a drug company are taking their fight to use the tribe’s sovereign immunity to shield it from inter partes review (IPR) of patents...
To view the full article, register now.